New Therapeutic Substances

Eleven new substance values were added to code table XW0, Anatomical Regions, Introduction, as noted below. Device/Substance/TechnologyJ Apalutamide Antineoplastic K Fosfomycin Anti-infective L Erdafitinib Antineoplastic N Meropenem-vaborbactam Anti-infective Q Tagraxofusp-erzs Antineoplastic R Venetoclax Antineoplastic S Iobenguane I-131Antineoplastic T Ruxolitinib U Imipenem-cilastatin-relebactam Anti-infective V Gilteritinib Antineoplastic W Caplacizumab Apalutamide Antineoplastic Apalutamide, also known by its trade name ERLEADA™, is an oral androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (NM-CRPC). Prostate cancer that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone...

Subscribe or sign in to view the full article.

articles:   
Note:  The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.

Article Overview

This article covers a set of newly added therapeutic substances in an ICD-10-PCS code table and explains the broad clinical context for each substance. It is useful for coding professionals, CDI staff, and health information teams who need to understand what changed, which specialty areas are affected, and how the substances are grouped by therapeutic category.

Why This Topic Matters

Updates to therapeutic substance tables can affect inpatient procedure coding, documentation review, and awareness of newly recognized drugs and biologic agents. The article helps readers identify the scope of the update and the kinds of therapies involved without replacing the premium coding detail.

Article Sections

  1. New substance values added to code table XW0

    Introduces the new therapeutic substance values added to the ICD-10-PCS table and organizes them by general substance category.

  2. Individual therapeutic substance summaries

    Provides broad clinical overviews for each newly added substance, including the conditions and therapy areas associated with them.

What You Will Learn

  • Which therapeutic substance values were added to the ICD-10-PCS table
  • What general drug and biologic categories are covered in the update
  • Which clinical areas and disease groups are associated with the newly added substances
  • Why the update is relevant to inpatient coding and documentation review

Who Should Read This

  • Inpatient coders
  • Clinical documentation integrity specialists
  • Health information management professionals
  • Coding auditors
  • Revenue cycle and reimbursement staff

Subscribe or sign in to view the full article.

articles:   
  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?